Literature DB >> 1602483

X-ray solution scattering reveals conformational changes upon iron uptake in lactoferrin, serum and ovo-transferrins.

J G Grossmann1, M Neu, E Pantos, F J Schwab, R W Evans, E Townes-Andrews, P F Lindley, H Appel, W G Thies, S S Hasnain.   

Abstract

X-ray solution scattering has been used for studying the structural changes that take place upon uptake and release of iron from serum and chicken ovo-transferrin and human lactoferrin. In the case of chicken ovo-transferrin, data have been obtained for both the intact protein and the isolated N and C-lobes with and without iron. These studies reveal that both lobes undergo a change that is consistent with an opening of the inter-domain cleft when iron is removed from the protein. We suggest that the conformational change of the protein increases the specificity of receptor binding and that the closed configuration of the iron-loaded protein is one, or perhaps the, decisive step in the mechanism for receptor-mediated endocytosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1602483     DOI: 10.1016/0022-2836(92)90402-6

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  21 in total

1.  Molecular modeling of human serum transferrin for rationalizing the changes in its physicochemical properties induced by iron binding. Implication of the mechanism of binding to its receptor.

Authors:  H Yajima; T Sakajiri; T Kikuchi; M Morita; T Ishii
Journal:  J Protein Chem       Date:  2000-04

2.  Apo- and holo-lactoferrin are both internalized by lactoferrin receptor via clathrin-mediated endocytosis but differentially affect ERK-signaling and cell proliferation in Caco-2 cells.

Authors:  Rulan Jiang; Veronica Lopez; Shannon L Kelleher; Bo Lönnerdal
Journal:  J Cell Physiol       Date:  2011-11       Impact factor: 6.384

3.  Low-resolution structures of proteins in solution retrieved from X-ray scattering with a genetic algorithm.

Authors:  P Chacón; F Morán; J F Díaz; E Pantos; J M Andreu
Journal:  Biophys J       Date:  1998-06       Impact factor: 4.033

4.  Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111.

Authors:  D S Chapple; D J Mason; C L Joannou; E W Odell; V Gant; R W Evans
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

5.  An iron-dependent and transferrin-mediated cellular uptake pathway for plutonium.

Authors:  Mark P Jensen; Drew Gorman-Lewis; Baikuntha Aryal; Tatjana Paunesku; Stefan Vogt; Paul G Rickert; Soenke Seifert; Barry Lai; Gayle E Woloschak; L Soderholm
Journal:  Nat Chem Biol       Date:  2011-06-26       Impact factor: 15.040

6.  Evaluation of the bioactivity of recombinant human lactoferrins toward murine osteoblast-like cells for bone tissue engineering.

Authors:  Ashley A Amini; Lakshmi S Nair
Journal:  Tissue Eng Part A       Date:  2013-02-19       Impact factor: 3.845

7.  Purified meningococcal transferrin-binding protein B interacts with a secondary, strain-specific, binding site in the N-terminal lobe of human transferrin.

Authors:  I C Boulton; A R Gorringe; B Gorinsky; M D Retzer; A B Schryvers; C L Joannou; R W Evans
Journal:  Biochem J       Date:  1999-04-01       Impact factor: 3.857

8.  A high-throughput method for the quantification of iron saturation in lactoferrin preparations.

Authors:  Grzegorz Majka; Klaudyna Śpiewak; Katarzyna Kurpiewska; Piotr Heczko; Grażyna Stochel; Magdalena Strus; Małgorzata Brindell
Journal:  Anal Bioanal Chem       Date:  2013-04-21       Impact factor: 4.142

9.  In vivo diffusion of lactoferrin in brain extracellular space is regulated by interactions with heparan sulfate.

Authors:  Robert G Thorne; Aparna Lakkaraju; Enrique Rodriguez-Boulan; Charles Nicholson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-09       Impact factor: 11.205

10.  IsdA protects Staphylococcus aureus against the bactericidal protease activity of apolactoferrin.

Authors:  Simon R Clarke; Simon J Foster
Journal:  Infect Immun       Date:  2008-01-28       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.